This compound is a deuterium-labeled derivative of acyclovir, used as an active pharmaceutical ingredient. It is characterized by the replacement of four hydrogen atoms with deuterium in the acyclic side chain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Valacyclovir hydrochloride
pharmaceutical raw material
Umifenovir hydrochloride
pharmaceutical raw material
Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate
pharmaceutical raw material
Lamivudine
pharmaceutical raw material
DL-Benflumelol-d18
pharmaceutical raw material
All-trans Acitretin-d3
pharmaceutical raw material
Mycophenolic acid-d3
pharmaceutical raw material
Prusogliptin
pharmaceutical raw material
2-amino-9-[(1,1,2,2-tetradeuterio-2-hydroxyethoxy)methyl]-1H-purin-6-one
MKUXAQIIEYXACX-LNLMKGTHSA-N
[2H]C([2H])(C([2H])([2H])OCN1C=NC2=C1N=C(NC2=O)N)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.